CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs

PLoS Neglected Tropical Diseases

Volumn 6, Issue 11, 2012, Pages

  Goodhew, E Brook ^a   Priest, Jeffrey W ^b   Moss, Delynn M ^b   Zhong, Guangming ^c   Munoz, Beatriz ^d   Mkocha, Harran ^e   Martin, Diana L ^a   West, Sheila K ^d   Gaydos, Charlotte ^f   Lammie, Patrick J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Kongwa Trachoma Project   (Tanzania)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL ANTIGEN; CT694 PROTEIN; PGP3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CROSS REACTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TRACHOMA;

ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; AZITHROMYCIN; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFANT; LYMPHOGRANULOMA VENEREUM; MALE; SENSITIVITY AND SPECIFICITY; TANZANIA;

EID: 84870764301     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001873     Document Type: Article

References (23)

1. Mariotti SP, Pascolini D, Rose-Nussbaumer J, (2009) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563-568.
2. Frick KD, Basilion EV, Hanson CL, Colchero MA, (2003) Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 10: 121-132.
3. Munoz B, Stare D, Mkocha H, Gaydos C, Quinn T, et al. (2011) Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci 52: 8806-8810.
4. Burton MJ, Hu VH, Massae P, Burr SE, Chevallier C, et al. (2011) What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting. Invest Ophthamol Vis Sci 52: 6012-6017.
5. See CW, Alemayehu W, Melese M, Zhou Z, Porco TC, et al. (2011) How reliable are tests for trachoma? - a latent class approach. IOVS 52: 6133-6137.
6. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D, (1999) The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiol Infect 123: 479-486.
7. Solomon AW, Peeling RW, Foster A, Mabey DCW, (2004) Diagnosis and assessment of trachoma. Clin Microbiol Rev 17: 982-1011.
8. Moss DM, Priest JW, Boyd A, Weinkopff T, Kucerova Z, et al. (2011) Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. Am J Trop Med Hyg 85: 229-237.
9. Zhou XN, Xu J, Chen HG, Wang TP, Huang XB, et al. (2011) Tools to support policy decisions related to treatment strategies and surveillance of Schistosomiasis japonica towards elimination. PLoS Negl Trop Dis 5: e1408.
10. Gass K, Beau de Rochars MVE, Boakye D, Bradley M, Fischer PU, et al. (2012) A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate Bancroftian filariasis. PLoS Negl Trop Dis 6: e1479.
11. Ghaem-Maghami S, Ratti G, Ghaem-Maghami M, Comanducci M, Hay PE, et al. (2003) Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection. Clin Exp Immunol 132: 436-432.
12. Stare D, Harding-Esch E, Munoz B, Bailey R, Mabey D, et al. (2011) Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the partnership for rapid elimination of trachoma (PRET) in Tanzania and the Gambia. Ophthalmic Epidemiol 18: 20-29.
13. Ssemanda EN, Munoz B, Harding-Esch EM, Edwards T, Mkocha H, et al. (2010) Mass treatment with azithromycin for trachoma control: participation clusters in households. PLoS Negl Trop Dis 4 (10): e838.
14. Thylefors B, Chylack LT Jr, Konyama K, Sasaki K, Sperduto R, et al. (2002) A simplified cataract grading system. Ophthalmic Epidemiol 9: 83-95.
15. Wang J, Zhang Y, Lu C, Lei L, Yu P, et al. (2010) A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol 185: 1670-1680.
16. Wills GS, Horner PJ, Reynolds R, Johnson AM, Muir DA, et al. (2009) Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clin Vaccine Immunol 16: 835-843.
17. Hower S, Wolf K, Fields KA, (2009) Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol 72: 1423-1437.
18. Priest JW, Kwon JP, Moss DM, Roberts JM, Arrowood MJ, et al. (1999) Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigens. J Clin Microbiol 37: 1385-1392.
19. Frikha-Gargouri O, Gdoura R, Znazen A, Gargouri J, Rebai A, et al. (2009) Diagnostic value of an enzyme-linked immunosorbent assay using the recombinant CT694 species-specific protein of Chlamydia trachomatis. J Appl Microbiol 107: 1875-1882.
20. Mygind P, Christiansen G, Persson K, Birkelund S, (2000) Detection of Chlamydia trachomatis-specific antibodies in human sera by recombinant major outer-membrane protein polyantigens. J Med Microbiol 49: 457-465.
21. Bas S, Muzzin P, Ninet B, Bornand JE, Scieux C, et al. (2001) Chlamydial serology: comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens. J Clin Microbiol 39: 1368-1377.
22. Hammerschlag MR, (2004) Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents. Pediatr Rev 25: 43-51.
23. Hobson D, Rees E, (1977) Maternal genital chlamydial infection as a cause of neonatal conjunctivitis. Postgrad Med J 53: 595-597.